Drug Trial Radar · NCT05080465
Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis
Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
700
Actual
Start
Dec 2, 2018
Primary completion
Oct 7, 2024
Study completion Jan 30, 2025
Sponsor
- Lead sponsor
- Ukraine Association of BiobankAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 69 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to assess safety and preliminary clinical activity of treatments of liver cirrhosis in patients with caused by Hepatitis C and Hepatitis B or Nonalcoholic Steatohepatitis of Mesenchymal stem cell. Patients who will be enrolled in the study will be under supervision and monitoring to ensure clinical significance
Conditions
- Liver Cirrhosis
Interventions
Autologous BM MSCBiological
A total of 100-200ml will be harvested from the subject, in either a single or multiple punctures. This will be processed for autologous MSC infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MR ElastographyTime frame: Change from Baseline (Day 0) until 40 weeks
- The level of serum alanine aminotransferase (ALT)Time frame: Change from Baseline (Day 0) until 40 weeks
- Clinical ExaminationTime frame: Change from Baseline (Day 0) until 40 weeks
- The level of glomerular filtration rate (GFR)Time frame: Change from Baseline (Day 0) until 40 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institute of Bio-Stem Cell Rehabilitation
Kharkiv, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.